| Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid A deacylase PagL as a novel acellular vaccine candidate CJA Asensio, ME Gaillard, G Moreno, D Bottero, E Zurita, M Rumbo, ... Vaccine 29 (8), 1649-1656, 2011 | 124 | 2011 |
| Pertussis epidemiology in Argentina: trends over 2004–2007 D Hozbor, F Mooi, D Flores, G Weltman, D Bottero, S Fossati, C Lara, ... Journal of Infection 59 (4), 225-231, 2009 | 114 | 2009 |
| Characterization of the immune response induced by pertussis OMVs-based vaccine D Bottero, ME Gaillard, E Zurita, G Moreno, DS Martinez, E Bartel, S Bravo, ... Vaccine 34 (28), 3303-3309, 2016 | 75 | 2016 |
| Outer membrane vesicles derived from Bordetella parapertussis as an acellular vaccine against Bordetella parapertussis and Bordetella pertussis infection D Bottero, ME Gaillard, A Errea, G Moreno, E Zurita, L Pianciola, ... Vaccine 31 (45), 5262-5268, 2013 | 50 | 2013 |
| The stimulated innate resistance event in Bordetella pertussis infection is dependent on reactive oxygen species production E Zurita, G Moreno, A Errea, M Ormazabal, M Rumbo, D Hozbor Infection and immunity 81 (7), 2371-2378, 2013 | 14 | 2013 |
| Pertussis vaccine candidate based on outer membrane vesicles derived from biofilm culture F Carriquiriborde, P Martin Aispuro, N Ambrosis, E Zurita, D Bottero, ... Frontiers in Immunology 12, 730434, 2021 | 13 | 2021 |
| Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern E Rudi, P Martin Aispuro, E Zurita, MM Gonzalez Lopez Ledesma, ... Frontiers in immunology 13, 1020159, 2022 | 6 | 2022 |
| Active surveillance of asymptomatic, presymptomatic, and oligosymptomatic SARS-CoV-2-infected individuals in communities inhabiting closed or semi-closed institutions N Ambrosis, P Martin Aispuro, K Belhart, D Bottero, RL Crisp, MV Dansey, ... Frontiers in Medicine 8, 640688, 2021 | 5 | 2021 |
| Outer membrane vesicles derived from Bordetella pertussis are potent adjuvant that drive Th1-biased response B Pschunder, L Locati, O López, P Martin Aispuro, E Zurita, M Stuible, ... Frontiers in Immunology 15, 1387534, 2024 | | 2024 |
| Heterologous booster with a novel formulation containing glycosylated trimeric S protein is effective against Omicron D Bottero, E Rudi, P Martin Aispuro, E Zurita, E Gaillard, ... Frontiers in Immunology 14, 1271209, 2023 | | 2023 |
| Cambios en la propuesta didáctica de una materia de primer año acompañando la modalidad de dictado: presencial/virtual/híbrida G Moreno, A Graieb, J Tack, A Martínez, ME Zurita, ... Universidad Nacional de La Plata, 2022 | | 2022 |
| Vaccines for the prevention of infections with Bordetella D Hozbor, D Bottero, ME Gaillard, E Zurita, M Omazabal, D Flores, ... US Patent 9,623,102, 2017 | | 2017 |
| Translational Medicine D Bottero, ME Gaillard, E Zurita, G Moreno, DS Martinez J Med 52, 107-113, 2016 | | 2016 |
